Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Growth in Prescription Dermatological Drug Market - Happi
Company News

Growth in Prescription Dermatological Drug Market

Sales rise 7.9% between 2013-2015.

The worldwide market for prescription dermatological drugs exceeded $21 billion last year, growing at a rate of 7.9% from 2013 to 2015, according to a report from Kalorama Information.
 
In its report, “World Market for Prescription Dermatological Drugs, 9th Edition (Anti-acne, Anti-aging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments),” Kalorama notes that driving forces include growth and aging of the worldwide population, new products and technologies, and focus on lifestyle treatments that improve the effects of aging and damage to the skin.
 
The psoriasis and skin cancer treatments dermatology drug sectors were among those that showed dramatic gain in the last two years.
 
Sales of prescription acne and rosacea and other drugs reflected a slower growth rate during this period because many of the drugs are older and have lost patent protection, noted the firm.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters